Multifocal Motor Neuropathy: Weakness Without Numbness, and the Treatment That Holds It Back
Last updated September 4, 2026.
Multifocal motor neuropathy, MMN, is a rare condition in which the immune system attacks the motor nerves, the wires that carry instructions from brain to muscle. The result is weakness that slowly spreads, typically starting in a hand or forearm, without numbness or pain, because the sensory nerves are spared. It is often mistaken at first for carpal tunnel syndrome or, more frighteningly, for motor neuron disease, and getting the right diagnosis matters because MMN is treatable.
What the immune attack does
The attack targets the insulation at scattered points along the motor nerves, blocking the signal at those points while the nerve itself survives. Muscles served by a blocked nerve weaken and eventually shrink. The pattern is patchy and one-sided at first: a dropped grip in one hand, a foot that catches, wasted muscle between thumb and finger. Reflexes fade in the affected limb. Sensory testing comes back normal, which is the big diagnostic clue, and electrical studies show the characteristic signal blocks. Many people carry a specific antibody, anti-GM1, which helps confirm it.
MMN is weakness without numbness, slow and treatable. IVIG holds it for most people, steroids make it worse, and it is not ALS: the electrical studies that diagnosed it are exactly what tells the two apart.
Start a free AI doctor consult →What it is not
The diagnosis everyone dreads in this territory is ALS. The distinction matters and the doctors check it carefully: MMN has no upper motor neuron signs, moves slowly over years, spares sensation, and responds to immune treatment, none of which is true of ALS. If your specialist has landed on MMN after electrical studies, that is a diagnosis with a treatment attached.
How it is treated
The mainstay is intravenous immunoglobulin, IVIG, a purified blood product that dampens the immune attack. Most people improve with it, often noticeably within weeks of the first course, and then stay on regular infusions, every few weeks, to hold the ground. Some move to home infusions or a form given under the skin. Two things are unusual about MMN treatment and worth knowing: steroids, the default for so many immune conditions, do not work here and can make it worse, and there is no proven role for most other immune drugs, which is why IVIG stays central. Untreated, the weakness slowly spreads over years; treated, most people hold their function, keep working, and live full lives, with grip and fine finger tasks the usual lasting trouble.
- Keep the infusion rhythm. IVIG wears off on a schedule your body sets. If strength fades before the next infusion, tell the team; the interval or dose can be tuned, and skipping infusions lets the weakness advance.
- Steroids are the wrong tool here. If a new prescriber reaches for steroids for this, make sure they know the MMN diagnosis; it is one of the rare immune conditions where steroids backfire.
- Report new weakness early. A new patch of weakness means a new signal block, and earlier treatment protects the nerve behind it. Track your grip and function between visits.
If you are weighing the risks and benefits of any medicine mentioned here, our overview of how medicines are tested and monitored for safety explains what those conversations are built on.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Is multifocal motor neuropathy the same as ALS?
No. Both cause weakness without numbness, but MMN is an immune condition that responds to treatment and progresses slowly over decades, while ALS is degenerative and progressive. Electrical studies, examination findings, and the treatment response tell them apart.
What causes MMN?
The immune system attacks insulation at scattered points along the motor nerves, blocking the signal to the muscles. Why it starts is not known. Many people carry an antibody called anti-GM1, which supports the diagnosis.
Does IVIG really work?
Yes, for most people. Strength often improves within weeks of the first courses, and regular maintenance infusions hold the gains. The dose and interval are tuned to how your strength holds between infusions, and home or under-the-skin forms exist for the long term.
Why can't I just take steroids?
Steroids, the usual first move in immune conditions, do not help MMN and can make it worse. It is one of the rare exceptions, and it is worth stating your diagnosis clearly to any new prescriber.
Will it keep spreading?
Untreated, it slowly spreads to new nerves over years. On regular IVIG, most people hold their function long-term. New patches of weakness should be reported early, because treatment protects a nerve better before its muscle shrinks.
Will I be able to keep working?
Most people do. Grip and fine finger tasks are the usual lasting difficulty, sometimes needing tools or adaptations. Walking, driving, and independence are the expectation with treatment.